Digital nurse companion: could an app ease the burden of chronic illness?

NCT ID NCT05750953

Completed Symptom relief Sponsor: University of Stavanger Source: ClinicalTrials.gov ↗

First seen Aug 14, 2026 · Last updated Aug 14, 2026

Summary

This trial tests a nurse-assisted eHealth program for patients with heart failure or colorectal cancer. After leaving the hospital, participants use a tablet with the MyDignio app to track vital signs and symptoms, and communicate with a nurse navigator. The goal is to see if this support boosts patients' confidence in managing their condition and improves their experience with treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: A nurse-assisted eHealth intervention using a tablet with the MyDignio app and Bluetooth monitoring devices for daily vital signs and symptom tracking.
What this could lead to: If effective, this approach could improve patients' confidence and ability to manage chronic conditions at home, potentially reducing hospital readmissions and improving quality of life.
What could go wrong: The trial is relatively small and focuses on short-term outcomes, so benefits may not be lasting or generalizable. Some patients may find the technology difficult to use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLON CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

colon carcinoma colonic neoplasm colorectal cancer heart failure Noncommunicable Diseases rectal cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COLON RECTAL CANCER HEART FAILURE NON COMMUNICABLE DISEASES

Contacts and locations

Locations

Anne Marie Lunde Husebø

Stavanger, Rogaland, 4036, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.